Crossmark

The lived experience of patients with breast cancer on adjuvant endocrine therapy: side effects and coping strategies during the first year of medication initiation

Crossref DOI link: https://doi.org/10.1007/s00520-023-08170-y

Published Online: 2023-11-27

Published Print: 2023-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gomaa, Sameh

Lopez, AnaMaria

Slamon, Rachel

Smith, Rita

Lapitan, Emmanuel

Nightingale, Ginah

Miller, Suzanne M.

Wen, Kuang-Yi
Funding

Funding for this research was provided by:

National Cancer Institute (5R01CA222246-04)
License Information

Text and Data Mining valid from 2023-11-27

Version of Record valid from 2023-11-27
More Information

Article History

Received: 20 January 2023

Accepted: 7 November 2023

First Online: 27 November 2023

Declarations

:

: All subjects gave their informed consent for inclusion before they participated in the study. The study was conducted in accordance with 45 CFR 46. 109 (f)(1), and the protocol was approved by the Ethics Committee of Thomas Jefferson University IRB using control number 19F.265.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below